ReviewJournal of thoracic disease2025
Digital tomosynthesis for navigational bronchoscopy: a clinical practice review.
Review in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Learning curve, safety and diagnostic yield of the GalaxyJournal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary nodules, defined as single opacities up to 30 mm within normal lung tissue, are more frequently detected as a result of enhanced lung cancer screening methods utilizing low-dose computed tomography (LDCT), which has significantly reduced the mortality rate of lung cancer. The National Lung Screening Trial (NLST) highlighted that 39% of participants exhibited nodules, with a substantial proportion requiring further evaluation. The United States Preventive Services Task Force (USPSTF) has since recommended routine LDCT screening for high-risk individuals. Traditionally, lung nodule evaluation relied on risk prediction calculators, guiding management through serial imaging or biopsies. Computed tomography (CT)-guided transthoracic needle biopsy (TTNB) has been the gold standard for minimally invasive biopsy. However, its limitations include higher complication rates, especially for smaller and more central nodules. Navigational bronchoscopy (NB) offers a safer alternative, enabling the assessment of multiple nodules in one session along with concomitant mediastinal and hilar lymph node evaluation utilizing endobronchial ultrasound (EBUS). One of the challenges of bronchoscopic biopsy of lung nodules has been CT-body divergence, limiting diagnostic yield and accuracy. In order to combat this challenge, recent advancements in NB technology, particularly the integration of digital tomosynthesis (DT), enhance procedural visualization and has been shown to improve diagnostic yield. This clinical practice review emphasizes the significance of optimizing intraoperative ventilator techniques as well as integrating enhanced imaging modalities like DT and cone beam CT (CBCT) in order to overcome CT-body divergence and subsequently improving localization and biopsy outcomes. Preliminary studies indicate promising diagnostic yields by integrating these advanced imaging technologies. Ongoing research is essential to refine these approaches and improve patient outcomes in lung nodule management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.